An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Ranibizumab
Related studies linked through entity extraction aliases.
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ESBA1008 Microvolume Study
- Status
- COMPLETED
- Phase
- PHASE2
To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3
Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)
- Status
- COMPLETED
- Phase
- PHASE4
Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.
- Status
- COMPLETED
- Phase
- PHASE3
Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.
- Status
- COMPLETED
- Phase
- PHASE4
Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion
- Status
- UNKNOWN
- Phase
- PHASE4
Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment
- Status
- COMPLETED
- Phase
- PHASE2
Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab
- Status
- COMPLETED
- Phase
- PHASE4
Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision
- Status
- TERMINATED
- Phase
- PHASE4
Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)
- Status
- COMPLETED
- Phase
- PHASE4
Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)
- Status
- UNKNOWN
- Phase
- NA
Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis
- Status
- UNKNOWN
- Phase
- PHASE4
Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye
- Status
- COMPLETED
- Phase
- PHASE3
Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3